Whether you’re navigating early-stage clinical development decisions or contemplating the acquisition of a new external pharmaceutical asset, strategic due diligence is key to maximizing value.
But without data-driven insights, how can you ensure you understand the market opportunity and the factors influencing the likely success of your asset?
Our seasoned team of industry experts work quickly and collaboratively, gathering evidence-based insights to help you determine if there is potential for your asset. By combining our cutting-edge in-house technology and passion for data science with our strategic market access expertise, our team can support you in forecasting clinical and launch success, and provide recommendations to establish a narrative to communicate key areas of differentiation.
What we offer:
- Epidemiology
- ~The potential size of the addressable patient population
- Clinical landscaping
- ~The unmet need and burden of disease
- Competitor analysis
- ~The current and future competitive landscapes to recognize key opportunities
- ~Potential market opportunities and scope for product differentiation
- ~Previous regulatory & HTA decisions and approvals
- ~Competitor trial profiling and trial requirements/feasibility planning
- Price landscaping
- ~ Potential price benchmarks to inform early pricing assumptions
- ~ Market sizing and potential market opportunity evaluation
